Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SURGYNAL : revenue, balance sheet and financial ratios

SURGYNAL is a French company founded 15 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in DARDILLY (69570), this company of category PME shows in 2023 a net income positive of 35 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SURGYNAL (SIREN 527780910)
Indicator 2023 2017
Revenue N/C N/C
Net income 34 912 € 2 655 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2023, SURGYNAL generates positive net income of 35 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 3 k€ -> 35 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

34 912 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 409%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

409.268%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.114%

Solvency indicators evolution
SURGYNAL

Sector positioning

Debt ratio
409.27 2023
2017
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Watch

In 2023, the debt ratio of SURGYNAL (409.27) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
10.11% 2023
2017
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Average -10 pts over 2 years

In 2023, the financial autonomy of SURGYNAL (10.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of SURGYNAL in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of SURGYNAL is estimated at 28 680 € (range 10 916€ - 104 738€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
124 transactions
10k€ 28k€ 104k€
28 680 € Range: 10 916€ - 104 738€
NAF 5 all-time

Valuation method used

Net Income Multiple
34 912 € × 0.8x = 28 681 €
Range: 10 916€ - 104 738€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare SURGYNAL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about SURGYNAL

What is the revenue of SURGYNAL ?

The revenue of SURGYNAL is not publicly disclosed (confidential accounts filed with INPI).

Is SURGYNAL profitable?

Yes, SURGYNAL generated a net profit of 35 k€ in 2023.

Where is the headquarters of SURGYNAL ?

The headquarters of SURGYNAL is located in DARDILLY (69570), in the department Rhone.

Where to find the tax return of SURGYNAL ?

The tax return of SURGYNAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SURGYNAL operate?

SURGYNAL operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.